Nanoparticle-based drug delivery systems are designed to reach tumor sites based on their enhanced permeation and retention effects. However, a lack of interaction of these nanoparticles with cancer cells might lead to reduced uptake in the tumors, which might compromise the therapeutic efficacy of the system. Therefore, we developed bortezomib and IR-820-loaded hybrid-lipid mesoporous silica nanoparticles conjugated with the hydrophobic-binding peptide, cyclosporine A (CsA), and referred to them as CLMSN/BIR. Upon reaching the tumor site, CsA interacts hydrophobically with the cancer cell membranes to allow effective uptake of the nanoparticles. Nanoparticles ∼160 nm in size were prepared and the stability of IR-820 significantly improved. High cellular uptake of the nanoparticles was evident with pronounced apoptotic effects in PANC-1 and MIA PaCa-2 cells that were mediated by the chemotherapeutic effect of bortezomib and the photothermal and reactive oxygen species generation effects of IR-820. An in vivo biodistribution study indicated there was high accumulation in the tumor with an enhanced photothermal effect in PANC-1 xenograft mouse tumors. Furthermore, enhanced antitumor effects in PANC-1 xenograft tumors were observed with minimal toxicity induction in the organs of mice. Cumulatively, these results indicated the promising effects of CLMSN/BIR for effective chemo-phototherapy of pancreatic cancers.
Dense nonaqueous phase liquids (DNAPLs) like trichloroethylene (TCE) serve as the most common form of groundwater pollution in the world. Potassium permanganate (KMnO4) is a strong oxidant that can quickly destroy DNAPLs into innocuous products. Slow-release permanganate gel (SRPG), a mixture of colloidal silica (CS) and KMnO4, has been recently developed as novel treatment option for dilute and large plumes of DNAPLs in groundwater. The objective of this study was to characterize and optimize gelling and release properties of a SRPG solution in saturated porous media. It was hypothesized that CS and KMnO4 content of the SRPG constrain gelation and release duration. Batch and column tests showed that gelation could be delayed through manipulation of the KMnO4 content. In column tests, silica content had little effect on the gelation lag stage and release rate but influenced duration of permanganate release. Flow tank tests comparing Bindzil 1440 (B-40) SRPGs with pure KMnO4 solutions under varying media conditions demonstrated that the presence of CS enhanced lateral spread and prolonged release duration of the oxidant.
Article SYNTHESIS AND BIOLOGICAL PROPERTIES OF SELECTED 2-ARYL-4(3H)-QUINAZOLINONES was published on October 1, 2004 in the journal Heterocyclic Communications (volume 10, issue 4-5).